Asthma Drugs Market is expected to reach US$ 37.62 billion by 2032 | Major Companies - AstraZeneca, GSK plc, Merck & Co., Inc., Sanofi, Amgen Inc.

Market Size and Growth:

The Global Asthma Drugs Market size reached US$ 25.72 billion in 2024 and is expected to reach US$ 37.62 billion by 2032, growing at a CAGR of 5.2% during the forecast period 2025-2032.

The Asthma Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/asthma-drugs-market?sz

The Asthma Drugs Market refers to the global industry focused on the development, manufacturing, and distribution of medications used to prevent, control, and relieve asthma symptoms. It includes inhaled corticosteroids, bronchodilators, leukotriene modifiers, biologics, and combination therapies, serving pediatric and adult patients across hospitals, clinics, and retail pharmacies.

Recent Key Developments of United States:

✅ December 2025: GSK secured FDA approval for Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe eosinophilic asthma in patients aged 12 and older.

✅ December 2025: Amneal Pharmaceuticals gained FDA approval for its albuterol sulfate inhalation aerosol, a generic equivalent of ProAir HFA, targeting a U.S. market worth about $1.5 billion annually.

✅ September 2025: AstraZeneca received FDA approval to expand the label of Airsupra (albuterol/budesonide) for adults with mild asthma, supported by data showing a 46% reduction in severe exacerbation risk.

Recent Key Developments of Europe:

✅ December 2025: The EMA's CHMP issued a positive opinion recommending approval of GSK's depemokimab (Exdensur) for severe asthma with type 2 inflammation in patients aged 12 and older, with a European Commission decision expected in Q1 2026.

✅ December 2025: EMA CHMP positive opinion for depemokimab also covers chronic rhinosinusitis with nasal polyps, highlighting its potential as the first ultra-long-acting biologic with twice-yearly dosing.

List of the Key Players in the Asthma Drugs Market:

AstraZeneca
GSK plc
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Regeneron Pharmaceuticals, Inc.
Sanofi
Amgen Inc.
Covis Pharma
Camber Pharmaceuticals, Inc.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/asthma-drugs-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Asthma Drugs Market:

By Drug Class: Inhaled Corticosteroids, Leukotriene Modifiers, Long-Acting Beta Agonists (LABAs), Quick-Relief Medications, Combination Inhalers, Biologics, Others.

By Route of Administration: Inhalation, Oral, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=asthma-drugs-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Asthma Drugs market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Asthma Drugs Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Asthma Drugs market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Asthma Drugs Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Asthma Drugs Market in 2025?
◆ What is the projected growth rate of the Asthma Drugs Market through 2033?
◆ Who are the key players in the Asthma Drugs Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.